Antiphospholipid Antibodies Do Not Seem to Be Associated With Deep Vein Thrombosis: A Case Control Study

Antiphospholipid antibodies (APAs) are associated with venous thromboembolism in patients with systemic lupus erythematosus (SLE). In patients without SLE, but with deep vein thrombosis (DVT) this association is established only for patients with lupus anticoagulant (LA). In a case-controlled study APAs were determined in 171 consecutive outpatients who underwent phlebography at the first episode of clinically suspected DVT of lower limbs. Phlebography confirmed the presence of DVT in 54 (32%) patients and excluded it in 117. Antiphospholipid antibodies (exluding LA) were detected in 5 (9.2%) of the 54 patients with DVT and in 7 (5.9%) of the 117 subjects without DVT, The prevalence of APAs tended to be higher in patients with DVT than in patients without DVT, but the difference was not statistically significant (p = 0.3%). Antiphospholipid antibodies in the absence of LA are not associated with DVT in symptomatic patients. Therefore future studies should be performed before changing our clinical approach in APA-A positive but LA-negative patients. Key Words: Antiphospholipid antibodies-Deep vein thrombosis.

[1]  P. Prandoni,et al.  Deep Venous Thrombosis and Lupus Anticoagulant , 1996, Thrombosis and Haemostasis.

[2]  A. Cogo,et al.  Prevalence of Antiphospholipid Antibodies and Lupus Anticoagulant in Juvenile Patients with Objectively Documented Deep-vein Thrombosis , 1996 .

[3]  P. Brill-Edwards,et al.  Antiphospholipid antibodies and venous thromboembolism. , 1995, Blood.

[4]  P. Prandoni,et al.  Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. , 1995, Stroke.

[5]  G. Hughes,et al.  The management of thrombosis in the antiphospholipid-antibody syndrome. , 1995, The New England journal of medicine.

[6]  D. Triplett.  Antiphospholipid-protein antibodies: laboratory detection and clinical relevance. , 1995, Thrombosis research.

[7]  P. Moerloose,et al.  Multicenter Evaluation of Nine Commercial Kits for the Quantitation of Anticardiolipin Antibodies , 1995, Thrombosis and Haemostasis.

[8]  J. Batlle,et al.  Prevalence, Follow-Up and Clinical Significance of the Anticardiolipin Antibodies in Normal Subjects , 1994, Thrombosis and Haemostasis.

[9]  V. Kakkar,et al.  A novel dysfunctional protein C (Protein C Padua 2) associated with a thrombotic tendency: substitution of Cys for Arg‐1 results in a strongly reduced affinity for binding of Ca++ , 1993, British journal of haematology.

[10]  R. Bick,et al.  Anticardiolipin antibodies and thrombosis. , 1992, Hematology/oncology clinics of North America.

[11]  M. Rosove,et al.  Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients , 1992, Annals of Internal Medicine.

[12]  D. Feinstein.  Lupus anticoagulant, anticardiolipin antibodies, fetal loss, and systemic lupus erythematosus [editorial; comment] , 1992 .

[13]  P. Moerloose,et al.  Anticardiolipin Antibodies in Acute Venous Thromboembolism , 1992, Thrombosis and Haemostasis.

[14]  J. T. ten Cate,et al.  Contrast Venography, the Gold Standard for the Diagnosis of Deep-Vein Thrombosis: lmprovement in Observer Agreement , 1992, Thrombosis and Haemostasis.

[15]  J. Denburg,et al.  The Relationship of Antiphospholipid Antibodies to Thromboembolic Disease in Systemic Lupus Erythematosus: A Cross-Sectional Study , 1991, Thrombosis and Haemostasis.

[16]  J. Lubinski,et al.  Patterns of anti-phospholipid antibody specificities. , 1991, Journal of clinical & laboratory immunology.

[17]  C. Legnani,et al.  Prevalence of High Levels of Antiphospholipid Antibodies in Otherwise Unexplained Juvenile Venous Thromboembolism , 1991, Thrombosis and Haemostasis.

[18]  C. Chesterman,et al.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Santoro,et al.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. , 1990, Annals of internal medicine.

[20]  D. Feinstein.  Lupus anticoagulant, anticardiolipin antibodies, fetal loss, and systemic lupus erythematosus. , 1992, Blood.

[21]  P. Kyrle,et al.  Anticardiolipin antibodies in patients with venous thrombosis. , 1991, Haemostasis.

[22]  A. Girolami,et al.  Antithrombin III Trento. A 'new' congenital AT III abnormality with a peculiar crossed-immunoelectrophoretic pattern in the absence of heparin. , 1984, Acta haematologica.